What antibiotics are given to mothers with chorioamnionitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Regimens for Mothers with Chorioamnionitis

The first-line antibiotic regimen for mothers with chorioamnionitis is intravenous ampicillin (2g every 6 hours) plus gentamicin (1.5mg/kg every 8 hours or 5mg/kg ideal body weight daily), with clindamycin (900mg every 8 hours) added at cord clamping for cesarean deliveries. 1

First-Line Treatment Options

  • Ampicillin (2g IV every 6 hours) plus gentamicin is the recommended first-line antimicrobial regimen for treatment of chorioamnionitis 1, 2
  • Daily dosing of gentamicin using ideal body weight (5mg/kg) has been shown to be associated with a lower risk of postpartum endometritis compared to traditional 8-hour dosing 3
  • For cesarean deliveries, clindamycin (900mg IV) should be administered at the time of umbilical cord clamping to provide additional anaerobic coverage 4, 1

Alternative Regimens for Penicillin-Allergic Patients

  • For penicillin-allergic patients without history of severe reactions (anaphylaxis, angioedema, respiratory distress, or urticaria), cefazolin is the preferred agent 5
  • For penicillin-allergic patients with history of severe allergic reactions, alternative regimens such as clindamycin or vancomycin should be considered 5
  • Broader spectrum agents might be necessary for treatment of chorioamnionitis in certain clinical scenarios 5

Duration of Antibiotic Therapy

  • For vaginal deliveries, evidence supports that one additional dose of antibiotics postpartum is sufficient therapy for immune-competent women with chorioamnionitis 4, 6
  • For cesarean deliveries, continuing antibiotics until the patient is afebrile and asymptomatic for 24 hours has traditionally been recommended, though some evidence suggests a limited course may be sufficient for many patients 4, 6
  • In a study of 292 women with chorioamnionitis, treatment failure rates did not differ between those who received one additional dose postpartum versus those who continued antibiotics until afebrile for 24 hours (4.6% vs 3.5%) 4

Emerging Treatment Options

  • Some research suggests a regimen including ceftriaxone, clarithromycin, and metronidazole may provide better coverage against commonly identified microorganisms in chorioamnionitis 1
  • Piperacillin-tazobactam is a broad-spectrum antibiotic that crosses the placenta in humans and may be considered in certain clinical scenarios, though there are insufficient data in pregnant women to fully establish safety profile 7

Important Considerations

  • Chorioamnionitis cannot be cured by antibiotic therapy alone without delivery, so prompt delivery should be considered once diagnosis is established 2
  • Antibiotic preferences may vary based on local policy, clinician experience, bacterial causes, antimicrobial resistance patterns, maternal allergies, and drug availability 2
  • Neonates born to mothers with chorioamnionitis should undergo a limited evaluation (blood culture and CBC with differential and platelet count) and receive antibiotic therapy pending culture results 8, 9

Pitfalls and Caveats

  • Treatment failure is more common after cesarean delivery (15%) compared to vaginal delivery (1%), suggesting that some patients who deliver by cesarean may benefit from a more extended course of antibiotic therapy 6
  • Obesity, prolonged labor, or prolonged rupture of membranes may increase risk of treatment failure and serious complications such as wound infection or septic thrombophlebitis 6
  • Consultation with obstetric providers is important to determine the level of clinical suspicion for chorioamnionitis, as some signs are nonspecific 5

References

Research

Management of clinical chorioamnionitis: an evidence-based approach.

American journal of obstetrics and gynecology, 2020

Research

Clinical chorioamnionitis: where do we stand now?

Frontiers in medicine, 2023

Research

Daily gentamicin using ideal body weight demonstrates lower risk of postpartum endometritis and increased chance of successful outcome compared with traditional 8-hour dosing for the treatment of intrapartum chorioamnionitis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2019

Guideline

Management of Chorioamnionitis Before Delivery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Chorioamnionitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.